Skip navigationThe Wellcome Trust Advanced Courses and Scientific Conferences

 
Questions or Queries

Telephone
:
+44 (0) 1223 495100

Email:

scientificconferences@ hinxton.wellcome.ac.uk

Home

Travel Information

Abstract Guidelines

Venue Details

Past Conferences

Sponsorship Opportunities

Terms and Conditions
 






Biomarkers for Brain Disorders: Challenges and Opportunities
3-5 February 2013
Møller Centre, Churchill College, Cambridge, UK

Registration now closed

 


We are pleased to announce the 2nd Wellcome Trust Scientific Conference on Biomarkers for Brain Disorders: Challenges and Opportunities. This conference will once again bring together leading neuroscientists from academia and industry involved in genomics, proteomics, diagnostics, imaging and regulatory affairs.

The discovery and validation of biomarkers in neurological and neurodegenerative diseases is an important challenge for early diagnosis of disease and for the development of therapeutics. Methodological and regulatory aspects of biomarker identification and qualification across a wide spectrum of neurodevelopmental, neurodegenerative and neuropsychiatric diseases will be discussed including, autism, Parkinson's disease, Alzheimer’s disease, multiple sclerosis and schizophrenia. There will also be a series of break-out sessions for in-depth discussion on the standardization of clinical biomarkers most likely to aid diagnosis and imaging-based studies in biomarker drug discovery. This meeting provides an opportunity for scientists from academia and the commercial sector to discuss the current ‘state of the art’ in biomarkers and will aid future investment decisions in both sectors.

Scientific organizers
Andreas Jeromin NextGen Sciences Dx, USA
Andy Lockhart GlaxoSmithKline, UK
William Potter formerly Merck, Inc., USA
Giovanni Frisoni IRCCS Fatebenefratelli, Brescia, Italy

Session Titles:
Neuropsychiatric disorders
Neurological disease
Neurodegenerative diseases
Neurodevelopmental biomarkers and targets
Standardization of clinical biomarkers
Imaging-based studies in biomarker drug discovery

Confirmed Speakers include:
Sabine Bahn, University of Cambridge, UK
Kaj Blennow University of Gothenburg, Sweden
Linda Brady NIMH, USA
Lucie Brujin ALS Association, USA
Chas Bountra Structural Genomics Consortium, UK
Christine Ecker Kings College London, UK
Harald Hampel University of Munchen, Germany
Ken Marek Institute for Neurodegenerative Disorders, USA
Jeff Nye Johnson & Johnson, USA
Simon Lovestone King's College London, UK
Kalpana Merchant Eli Lilly, USA
Emilio Merlo Pich Roche, Switzerland
Mark Schmidt Johnson & Johnson (Janssen), Belgium
Will Spooren Roche, Switzerland
Charlotte Teunissen  VU University Medical Center Amsterdam, The Netherlands

Programme
Click here to download the programme.

Please note: Owing to work to expand the Wellcome Trust Conference Centre at Hinxton, the 2013 conference will take place at the Møller Centre, Churchill College - part of the historic University of Cambridge.

 


Registration and Accommodation

Registration
The registration packages include registration and meals, with single accommodation at the Moller Centre being available at an additional cost. Please note there is a limited number of onsite accommodation available on a first come-first serve basis.

If you are required to make alternative accommodation arrangements, please visit www.visitcambridge.org for information on hotels in Cambridge.


Registration fees:

Student

No Accommodation

£480

Student

Single Accommodation

£676

Academic

No Accommodation

£580

Academic

Single Accommodation

£776

Commercial

No Accommodation

£680

Commercial

Single Accommodation

£876


Registration now closed



Abstracts and Posters

Abstracts and Posters
If you wish to submit an Abstract, please ensure that you follow the abstract guidelines and upload your abstract during registration.
Your abstract will be viewed by the Scientific Committee for an oral presentation or a poster presentation.

After the Abstract deadline of the 10 December 2012, the committee will make their selection, and you will be notified late December.
Poster boards onsite will accommodate 118 cm high by 84 cm wide (A0- portrait) of printed material. Accepted abstracts will appear in the conference programme book and poster boards will be allocated at the conference.

Abstract deadline:10 December 2012

If you have any questions please email Lucy Criddle directly: l.criddle@hinxton.wellcome.ac.uk



Supported/sponsored by:

   
     

 


 

 Gibbs Building, 215 Euston Road, London NW1 2BE, UK   tel:+44 (0)20 7611 8888   email:contact@wellcome.ac.uk